- Home
- SNTI vs ESGL Comparison
SNTI vs ESGL Comparison
Compare SNTI & ESGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- ESGL
- Stock Information
- Founded
- SNTI 2016
- ESGL 1999
- Country
- SNTI United States
- ESGL Singapore
- Employees
- SNTI N/A
- ESGL N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- ESGL
- Sector
- SNTI Health Care
- ESGL
- Exchange
- SNTI Nasdaq
- ESGL Nasdaq
- Market Cap
- SNTI 85.3M
- ESGL 76.4M
- IPO Year
- SNTI N/A
- ESGL N/A
- Fundamental
- Price
- SNTI $3.10
- ESGL $2.07
- Analyst Decision
- SNTI Strong Buy
- ESGL
- Analyst Count
- SNTI 1
- ESGL 0
- Target Price
- SNTI $12.00
- ESGL N/A
- AVG Volume (30 Days)
- SNTI 225.5K
- ESGL 18.1K
- Earning Date
- SNTI 05-06-2025
- ESGL 05-20-2025
- Dividend Yield
- SNTI N/A
- ESGL N/A
- EPS Growth
- SNTI N/A
- ESGL N/A
- EPS
- SNTI N/A
- ESGL N/A
- Revenue
- SNTI N/A
- ESGL $6,099,784.00
- Revenue This Year
- SNTI N/A
- ESGL N/A
- Revenue Next Year
- SNTI N/A
- ESGL N/A
- P/E Ratio
- SNTI N/A
- ESGL N/A
- Revenue Growth
- SNTI N/A
- ESGL N/A
- 52 Week Low
- SNTI $1.52
- ESGL $0.55
- 52 Week High
- SNTI $16.94
- ESGL $3.00
- Technical
- Relative Strength Index (RSI)
- SNTI 41.06
- ESGL 55.99
- Support Level
- SNTI $3.10
- ESGL $1.91
- Resistance Level
- SNTI $3.61
- ESGL $2.18
- Average True Range (ATR)
- SNTI 0.40
- ESGL 0.12
- MACD
- SNTI -0.07
- ESGL -0.00
- Stochastic Oscillator
- SNTI 9.50
- ESGL 67.65
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About ESGL ESGL Holdings Limited
ESGL Holdings Ltd Formerly Environmental Solutions Group Holdings Ltd is a waste management, treatment and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical and electroplating companies.